트롬빈 시장 규모, 점유율 및 성장 분석 : 제품별, 제형별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Thrombin Market size was valued at USD 662.96 Million in 2024 and is poised to grow from USD 699.42 Million in 2025 to USD 1073.4 Million by 2033, growing at a CAGR of 5.5% during the forecast period (2026-2033).

The global thrombin market is experiencing significant growth, driven by its essential role in hemostasis and blood coagulation, particularly within surgical and trauma settings. Increasing surgical procedures in areas like cardiovascular and orthopedic surgery, along with a rising elderly population, are key factors propelling market demand. Innovations, including recombinant thrombin, have improved product safety and efficacy while addressing concerns associated with animal-derived products. The market is further supported by expanding applications in biotechnology and pharmaceuticals, such as regenerative medicine and wound healing. North America leads the market due to its advanced healthcare infrastructure and favorable reimbursement policies, while Europe follows closely. Emerging markets in Asia-Pacific, particularly China and India, are poised for substantial growth, despite challenges from high manufacturing costs and regulatory hurdles.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Thrombin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Thrombin Market Segments Analysis

Global Thrombin Market is segmented by Product, Dosage Form, End-User and region. Based on Product, the market is segmented into Bovine Thrombin, Human Thrombin and Recombinant Thrombin. Based on Dosage Form, the market is segmented into Powder Form and Solution Form. Based on End-User, the market is segmented into Hospitals, Diagnostic Centers and Research Institutions. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Thrombin Market

The global demand for thrombin products is significantly driven by the rising number of surgical procedures, largely attributed to an ageing population and the increasing prevalence of non-communicable diseases such as cardiovascular disorders and cancer. With millions of surgical interventions conducted worldwide annually, thrombin plays a critical role in approximately 65% of cardiovascular surgeries and 55% of orthopedic operations, serving as a key local hemostatic agent to control bleeding. Additionally, the trend towards minimally invasive surgeries emphasizes the necessity for effective hemostatic solutions like thrombin, which ensures successful surgical outcomes by facilitating timely and skilled bleeding management.

Restraints in the Global Thrombin Market

The global thrombin market faces significant constraints due to the high costs associated with producing thrombin, particularly recombinant thrombin. This advanced biotechnology results in expensive products, which can limit their availability and usage, especially in economically challenged healthcare facilities in developing regions. As these facilities often opt for more affordable hemostatic alternatives, the high production costs create a barrier to market penetration and widespread application. Consequently, the financial constraints faced by many healthcare providers hinder the potential for thrombin products to be utilized effectively in settings where they are most needed.

Market Trends of the Global Thrombin Market

The global thrombin market is witnessing a significant shift towards recombinant thrombin products, reflecting an increasing preference for safer and purer alternatives to traditional bovine-source thrombin. This shift is being propelled by the rising demand for reliable hemostatic agents in surgical settings, particularly as the healthcare sector embraces minimally invasive techniques that require precise and effective hemostasis. Additionally, advancements in biotechnology and heightened awareness regarding patient safety are contributing to the growing adoption of recombinant options, positioning them as the preferred choice among healthcare professionals and institutions. Consequently, this trend is poised to reshape the competitive landscape of the thrombin market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Thrombin Market Size by Product & CAGR (2026-2033)

• Market Overview
• Bovine Thrombin
• Human Thrombin
• Recombinant Thrombin

Global Thrombin Market Size by Dosage Form & CAGR (2026-2033)

• Market Overview
• Powder Form
• Solution Form

Global Thrombin Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Centers
• Research Institutions

Global Thrombin Market Size & CAGR (2026-2033)

• North America (Product, Dosage Form, End-User)
  • US
  • Canada
• Europe (Product, Dosage Form, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Dosage Form, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Dosage Form, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Dosage Form, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai RAAS Blood Products Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Behring
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hualan Biological Engineering
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haematologic Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Octapharma AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omrix Biopharmaceuticals Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Japan Blood Products Organization
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mochida Pharmaceutical Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations